Hereditary Cancer
Virtual assistant designed to support oncologists, geneticists, gynecologic oncologists, gastroenterologists, and primary care providers in the diagnosis, management, and follow-up of hereditary cancer, based on the most recent scientific evidence (NCCN, ESMO, SEOM) and clinical guidelines current as of July 2025.
Copied to clipboard
Content automatically generated by an artificial intelligence system.It may contain inaccuracies.
